Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 5/2005

01-06-2005 | Original Articles

Tolerabilidad y efectividad del citrato de fentanilo oral transmucosa en el tratamiento a largo plazo del dolor irruptivo en pacientes oncológicos: estudio ECODIR

Authors: Vicente Valentín Maganto, Carlos Camps Herrero, Joan Carulla Torrent, Javier Cassinello Espinosa, Javier Dorta Delgado, Carlos Jara Sánchez, José Andrés Moreno Nogueira

Published in: Clinical and Translational Oncology | Issue 5/2005

Login to get access
Metadata
Title
Tolerabilidad y efectividad del citrato de fentanilo oral transmucosa en el tratamiento a largo plazo del dolor irruptivo en pacientes oncológicos: estudio ECODIR
Authors
Vicente Valentín Maganto
Carlos Camps Herrero
Joan Carulla Torrent
Javier Cassinello Espinosa
Javier Dorta Delgado
Carlos Jara Sánchez
José Andrés Moreno Nogueira
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Clinical and Translational Oncology / Issue 5/2005
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02712818

Other articles of this Issue 5/2005

Clinical and Translational Oncology 5/2005 Go to the issue

Case Reports

Local recurrence and metastatic disease in a typical N1 carcinoid bronchial tumour

Review

Adjuvant treatment of locally-advanced head and neck tumours

Case Reports

Cuirasse skin metastases secondary to gastric adenocarcinoma

News

News

Educational Review

Embryonic tumours of the central nervous system

Editorial

Postoperative radiotherapy with simultaneous chemotherapy in high-risk squamous cell carcinoma of the head and neck: a novel standard that opens new questions
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits